Samsung Bioepis Co. Ltd. has announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', ...

As small-molecule pipelines grow more complex, formulation has become a decisive factor in whether promising compounds reach ...

Rectify Pharmaceuticals has entered a strategic research and licensing agreement with Boehringer Ingelheim to accelerate the ...

Samsung Biologics America, a subsidiary of Samsing Biologics, a CDMO, has entered into a definitive agreement to acquire 100% ...

Nine leading global pharmaceutical companies announced broad agreements with the Trump administration on Friday to lower the ...

Symbiosis Pharmaceutical Services, a sterile fill finish contract manufacturing organization (CMO), has manufactured its first 10,000 vial batch at the company’s new facility in Stirling, UK.

Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.

ADEL Inc., a biopharma company, has entered into an exclusive worldwide license agreement with Sanofi for the development and ...

Gilead Sciences Inc. has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance effective ...

Harbour BioMed, a global biopharmaceutical company, has announced a multi-year, global strategic collaboration and license ...

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...

Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.